Is a single COVID-19 vaccine dose enough in convalescents ?
SARS-CoV-2 has infected more than 122 million persons worldwide. Most currently licensed COVID-19 vaccines require a two-dose course and many health systems are on a shortage of doses. The requirement for boosting the response after priming with the first dose is uncertain in convalescents already p...
Сохранить в:
| Главные авторы: | , , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Taylor & Francis Group
2021-09-01
|
| Серии: | Human Vaccines & Immunotherapeutics |
| Предметы: | |
| Online-ссылка: | http://dx.doi.org/10.1080/21645515.2021.1917238 |
| Метки: |
Нет меток, Требуется 1-ая метка записи!
|